Frankfurt am Main, Germany

Karl-Heinz Eisele

USPTO Granted Patents = 11 

 

 

Average Co-Inventor Count = 1.9

ph-index = 4

Forward Citations = 41(Granted Patents)


Company Filing History:


Years Active: 2014-2021

Loading Chart...
Loading Chart...
Loading Chart...
11 patents (USPTO):Explore Patents

Title: The Innovative Mind of Karl-Heinz Eisele

Introduction

Karl-Heinz Eisele, based in Frankfurt am Main, Germany, is a distinguished inventor with a remarkable portfolio of 11 patents. His groundbreaking innovations predominantly focus on neurotoxin sensitivity and induced pluripotent stem cell-derived neurons, contributing significantly to the field of neurobiology and cell culture systems.

Latest Patents

One of Eisele's latest inventions involves "Gangliosides for Standardizing and Increasing the Sensitivity of Cells to Botulinum Neurotoxins in In Vitro Test Systems." This patent outlines a method for developing induced pluripotent stem cell-derived neurons that exhibit standardized sensitivity to neurotoxin polypeptides. The steps include cultivating these neurons in a specific cell culture medium and assessing their responsiveness to neurotoxins.

Another significant patent focuses on "Cellular Test Systems for the Determination of the Biological Activities of Neurotoxin Polypeptides." This invention describes a process for generating neurotoxin-sensitive neuronal differentiated cells from tumor cells. It highlights how these cells can be cultivated and tested for their reaction to neurotoxin polypeptides, paving the way for advancements in neurotoxin research and testing.

Career Highlights

Karl-Heinz Eisele is currently associated with Merz Pharma GmbH & Co. Kgaa, a prominent company in the pharmaceutical industry. His contributions to the field of neurobiology have been pivotal, enabling researchers to better understand and mitigate the effects of neurotoxins.

Collaborations

Throughout his career, Eisele has collaborated with esteemed colleagues, including Harold Victor Taylor and Cornelia Brunn. These partnerships have fostered innovative approaches in developing cellular systems that are critical for understanding neurotoxin interactions.

Conclusion

Karl-Heinz Eisele exemplifies the spirit of innovation, with a dedicated focus on advancing neuroscience through his inventions. His work not only enhances scientific understanding but also has the potential to improve therapeutic strategies against neurotoxin-related challenges. With a strong foundation in his field, Eisele continues to drive impactful research and innovation.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…